Entasis Therapeutics Holdings Inc.
NASDAQ: ETTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Manoussos Perros
- Employees
- 51
- Headquarters
- Waltham, United States
- IPO year
- 2018
- Website
- https://www.entasistx.com
Loading ETTX…
Loading profile data…Frequently asked questions about ETTX
What does Entasis Therapeutics Holdings Inc. (ETTX) do?
Entasis Therapeutics Holdings Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to the discovery, development, and market introduction of novel antibacterial solutions. Their core mission in the United States is to address severe infections stemming from pathogens that exhibit multidrug resistance. A flagship program in t...
Where does ETTX trade?
Entasis Therapeutics Holdings Inc. (ETTX) trades on the NASDAQ Global Market.
What sector is ETTX in?
Entasis Therapeutics Holdings Inc. (ETTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Entasis Therapeutics Holdings Inc.?
Manoussos Perros is the chief executive officer of Entasis Therapeutics Holdings Inc. (ETTX).
Where is Entasis Therapeutics Holdings Inc. headquartered?
Entasis Therapeutics Holdings Inc. is headquartered in United States.
Does ETTX pay a dividend?
Entasis Therapeutics Holdings Inc. (ETTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ETTX go public?
Entasis Therapeutics Holdings Inc. (ETTX) completed its initial public offering in 2018.